Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy

Human Molecular Genetics

Volumn 22, Issue 13, 2013, Pages 2634-2641

  Wasala, Nalinda B ^a   Bostick, Brian ^a   Yue, Yongping ^a   Duan, Dongsheng ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; DIASTOLE; DISEASE SEVERITY; DUCHENNE MUSCULAR DYSTROPHY; HEART DISEASE; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART OUTPUT; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKELETAL MUSCLE; SYSTOLE; TRANSGENIC MOUSE; TREADMILL EXERCISE;

AGE FACTORS; ANIMALS; BODY WEIGHT; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; DYSTROPHIN; FIBROSIS; HEART VENTRICLES; MALE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIUM; ORGAN SIZE;

ANIMALIA; MUS;

EID: 84878941193     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt112     Document Type: Article

References (45)

1. American Academy of Pediatrics (2005) Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics, 116, 1569-1573.
2. Cox, G.F. and Kunkel, L.M. (1997) Dystrophies and heart disease. Curr. Opin. Cardiol., 12, 329-343.
3. Baxter, P. (2006) Treatment of the heart in Duchenne muscular dystrophy. Dev. Med. Child Neurol., 48, 163.
4. Kaspar, R.W., Allen, H.D. and Montanaro, F. (2009) Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. J. Am. Acad. Nurse Pract., 21, 241-249.
5. Heydemann, A. and McNally, E.M. (2007) Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy. Trends Cardiovasc. Med., 17, 55-59.
6. Burelle, Y., Khairallah, M., Ascah, A., Allen, B.G., Deschepper, C.F., Petrof, B.J. and Des Rosiers, C. (2010) Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart. J. Mol. Cell. Cardiol., 48, 310-321.
7. Duan, D. (2006) Challenges and opportunities in dystrophin-deficient cardiomyopathy Gene Therapy. Hum. Mol. Genet., 15, R253-R261.
8. Shin, J.-H., Bostick, B., Yue, Y. and Duan, D. (2010) In Duan, D (ed), Muscle Gene Therapy. Springer Science + Business Media, LLC, New York, pp. 141-162.
9. Lai, Y. and Duan, D. (2012) Progress in gene therapy of dystrophic heart disease. Gene Ther., 19, 678-685.
10. McNally, E.M. and Goldstein, J.A. (2012) Interplay between heart and skeletal muscle disease in heart failure: the 2011 George E. Brown Memorial Lecture. Circ. Res., 110, 749-754.
11. Megeney, L.A., Kablar, B., Perry, R.L., Ying, C., May, L. and Rudnicki, M.A. (1999) Severe cardiomyopathy in mice lacking dystrophin and MyoD. Proc. Natl. Acad. Sci. USA, 96, 220-225.
12. Crisp, A., Yin, H., Goyenvalle, A., Betts, C., Moulton, H.M., Seow, Y., Babbs, A., Merritt, T., Saleh, A.F., Gait, M.J. et al. (2011) Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. Hum. Mol. Genet., 20, 413-421.
13. Townsend, D., Yasuda, S., Li, S., Chamberlain, J.S. and Metzger, J.M. (2008) Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle. Mol. Ther., 16, 832-835.
14. Malerba, A., Boldrin, L. and Dickson, G. (2011) Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrity. Nucleic Acid Ther., 21, 293-298.
15. Harper, S.Q., Hauser, M.A., DelloRusso, C., Duan, D., Crawford, R.W., Phelps, S.F., Harper, H.A., Robinson, A.S., Engelhardt, J.F., Brooks, S.V. et al. (2002) Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med., 8, 253-261.
16. Tinsley, J., Deconinck, N., Fisher, R., Kahn, D., Phelps, S., Gillis, J.M. and Davies, K. (1998) Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat. Med., 4, 1441-1444.
17. Bostick, B., Shin, J.H., Yue, Y., Wasala, N.B., Lai, Y. and Duan, D. (2012) AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in. 21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. J. Mol. Cell. Cardiol., 53, 217-222.
18. Bostick, B., Yue, Y., Long, C., Marschalk, N., Fine, D.M., Chen, J. and Duan, D. (2009) Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged mdx mice. Mol. Ther., 17, 253-261.
19. Bostick, B., Yue, Y., Long, C. and Duan, D. (2008) Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/ utrophin expression. Circ. Res., 102, 121-130.
20. Bostick, B., Shin, J.-H., Yue, Y. and Duan, D. (2011) AAVmicrodystrophin therapy improves cardiac performance in aged female mdx mice. Mol. Ther., 19, 1826-1832.
21. Bostick, B., Yue, Y. and Duan, D. (2010) Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy. Muscle Nerve, 42, 600-603.
22. Li, D., Yue, Y., Lai, Y., Hakim, C.H. and Duan, D. (2011) Nitrosative stress elicited by nNOSmu delocalization inhibits muscle force in dystrophin-null mice. J. Pathol., 223, 88-98.
23. Hakim, C.H. and Duan, D. (2013) Truncated dystrophins reduce muscle stiffness in the extensor digitorium longus muscle of mdx mice. J. Appl. Physiol., 114, 482-489.
24. Bostick, B., Yue, Y. and Duan, D. (2011) Phenotyping cardiac gene therapy in mice. Methods Mol. Biol., 709, 91-104.
25. Yue, Y., Skimming, J.W., Liu, M., Strawn, T. and Duan, D. (2004) Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice. Hum. Mol. Genet., 13, 1669-1675.
26. Li, N. and Wehrens, X.H. (2010) Programmed electrical stimulation in mice. J. Vis. Exp., pii 1730.
27. Yin, H., Saleh, A.F., Betts, C., Camelliti, P., Seow, Y., Ashraf, S., Arzumanov, A., Hammond, S., Merritt, T., Gait, M.J. et al. (2011) Pip5 transduction peptides direct high efficiency oligonucleotide-mediated dystrophin exon skipping in heart and phenotypic correction in mdx mice. Mol. Ther., 19, 1295-1303.
28. Betts, C., Saleh, A.F., Arzumanov, A.A., Hammond, S.M., Godfrey, C., Coursindel, T., Gait, M.J. and Wood, M.J. (2012) Pip6-PMO, a new generation of peptide-oligonucleotide conjugates with improved cardiac exon skipping activity for DMD treatment. Mol. Ther. Nucleic Acids, 1, e38.
29. Arechavala-Gomeza, V., Anthony, K., Morgan, J. and Muntoni, F. (2012) Antisense oligonucleotide-mediated exon skipping for Duchenne muscular dystrophy: progress and challenges. Curr. Gene Ther., 12, 152-160.
30. Shin, J.H., Pan, X., Hakim, C.H., Yang, H.T., Yue, Y., Zhang, K., Terjung, R.L. and Duan, D. (2013) Microdystrophin ameliorates muscular dystrophy in the canine model of Duchenne muscular dstrophy. Mol. Ther., doi: 10.1038/mt.2012.283.
31. Yue, Y., Ghosh, A., Long, C., Bostick, B., Smith, B.F., Kornegay, J.N. and Duan, D. (2008) A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol. Ther., 16, 1944-1952.
32. Yasuda, S., Townsend, D., Michele, D.E., Favre, E.G., Day, S.M. and Metzger, J.M. (2005) Dystrophic heart failure blocked by membrane sealant poloxamer. Nature, 436, 1025-1029.
33. Townsend, D., Blankinship, M.J., Allen, J.M., Gregorevic, P., Chamberlain, J.S. and Metzger, J.M. (2007) Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-inducedc cardiac pump failure. Mol. Ther., 15, 1086-1092.
34. Park, O.Y., Ahn, Y., Park, W.S., Lim, J.H., Park, H.W., Kim, J.H., Hong, Y.J., Kim, W., Jeong, M.H., Cho, J.G. et al. (2005) Rapid progression from hypertrophic cardiomyopathy to heart failure in a patient with Becker's muscular dystrophy. Eur. J. Heart Fail., 7, 684-688.
35. Nigro, G., Comi, L.I., Politano, L. and Bain, R.J. (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int. J. Cardiol., 26, 271-277.
36. Li, D., Long, C., Yue, Y. and Duan, D. (2009) Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Hum. Mol. Genet., 18, 1209-1220.
37. Chamberlain, J.S., Metzger, J., Reyes, M., Townsend, D. and Faulkner, J.A. (2007) Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J., 21, 2195-2204.
38. Beer, M., Wagner, D., Myers, J., Sandstede, J., Kostler, H., Hahn, D., Neubauer, S. and Dubach, P. (2008) Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy. J. Am. Coll. Cardiol., 51, 1883-1891.
39. Cohen, N. and Muntoni, F. (2004) Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Heart, 90, 835-841.
40. Muntoni, F., Cau, M., Ganau, A., Congiu, R., Arvedi, G., Mateddu, A., Marrosu, M.G., Cianchetti, C., Realdi, G., Cao, A. et al. (1993) Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med., 329, 921-925.
41. Towbin, J.A., Hejtmancik, J.F., Brink, P., Gelb, B., Zhu, X.M., Chamberlain, J.S., McCabe, E.R. and Swift, M. (1993) X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation, 87, 1854-1865.
42. Neri, M., Valli, E., Alfano, G., Bovolenta, M., Spitali, P., Rapezzi, C., Muntoni, F., Banfi, S., Perini, G., Gualandi, F. et al. (2012) The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy. BMC Med. Genet., 13, 20.
43. Zhu, X., Wheeler, M.T., Hadhazy, M., Lam, M.Y. and McNally, E.M. (2002) Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy. FASEB J., 16, 1096-1098.
44. Mitchell, G.F., Jeron, A. and Koren, G. (1998) Measurement of heart rate and Q-T interval in the conscious mouse. Am. J. Physiol., 274, H747-H751.
45. Nigro, G., Comi, L.I., Politano, L. and Nigro, G. (2004) In Engel, A. and Franzini-Armstrong, C (eds), Myology: Basic and Clinical. McGraw-Hill, Medical Pub. Division, New York, Vol. 2, pp. 1239-1256.